In its second respiratory-focused deal of the month, Clario is partnering with Strados Labs to use its FDA-approved monitoring device for clinical trials. Under the agreement, Philadelphia-based ...

Opinions expressed by Digital Journal contributors are their own. As healthcare systems worldwide continue to address the effects of the COVID-19 pandemic, pharmaceutical companies like Amneal ...

Annually, a staggering 20 million individuals globally find themselves connected to invasive respiratory support systems like ECMO and CBP. These systems, while crucial for survival, often necessitate ...

As climate change worsens respiratory diseases, doctors and drugmakers are exploring earlier diagnosis and low-carbon inhalers to cut emissions from care and protect patients. For millions of people, ...

AI shows promise in diagnosing rare respiratory diseases but faces challenges like data privacy, bias, and hallucinations. Global equity in digital health access is crucial, with disparities ...